Account Director, Health Systems, Rare Disease
Ipsen
Summary
The Rare Health System Account Director serves as the Rare Disease Business Unit’s strategic lead for priority healthcare organizations across the Rare Disease Liver portfolio. This field-based role develops and executes Rare Disease specific account strategies focused on improving patient diagnosis and treatment pathways, referral and care coordination and access to Ipsen’s Rare Liver Disease treatments. The Account Director builds long-term partnerships with Integrated Delivery Networks (IDNs), academic centers of excellence, and other priority organized customers by identifying shared clinical, operational, and care-delivery priorities.
Job description
Main Responsibilities
Account Strategy & Planning
- Assess and diagnose barriers across the Rare Disease patient journey — referral, diagnosis, treatment access and initiation including clinical, operational, access, and business environment.
- Develop and maintain Rare Disease-specific account profiles, needs assessments, and coordinated account plans that align customer priorities with approved franchise and brand objectives.
- Identify and prioritize opportunities using customer insights, market dynamics, and quantitative and qualitative data.
- Establish Rare Disease account objectives, milestones, success measures, and action plans.
- Partner with Value & Access when identified account barriers involve product coverage, formulary policy, reimbursement, pricing, contracting, or economic evidence.
Customer Engagement and Strategic Partnership
- Build trusted relationships in collaboration with Ipsen cross-functional partners across executive, clinical, operational, and care-delivery stakeholders relevant to the Rare Disease patient journey.
- Engage account stakeholders to understand their strategic priorities, goals, challenges, and measures of success, and identify compliant opportunities for shared strategic priorities that benefit patients, providers and the health system.
- Facilitate strategic collaboration around patient diagnosis, referral, treatment access and care pathways, multidisciplinary coordination, and treatment delivery, using approved resources and in accordance with applicable policies.
- Strengthen Ipsen’s position as a Rare Liver Disease partner by sharing relevant insights and approved information that support appropriate patient identification, navigation, and delivery of care.
Cross-functional orchestration
- Serve as the Rare Disease Business Unit lead for coordinated planning and execution within priority health-system accounts.
- Lead Rare Disease-specific account planning, establishing shared objectives, roles, milestones, and communication routines with relevant partners.
- Coordinate Rare Disease resources and mobilize appropriate cross-functional partners without direct authority, prioritize approved resources and initiatives based on customer need, strategic fit, and potential patient and business impact.
- Ensure Rare Disease account insights inform relevant internal strategies and programs.
Insights, Measurement, and Impact
- Capture, synthesize, and communicate actionable customer and account insights to inform strategies.
- Establish and monitor progress against appropriate Rare Disease account objectives.
- Evaluate the effectiveness of Rare Disease account strategies and adjust plans and Rare Disease resources accordingly.
- Communicate results, patient journey barriers, emerging opportunities and account-level learnings to strengthen internal alignment and long-term customer partnerships.
- Ensure that all planning, engagement, information sharing, and execution utilize approved materials and comply with applicable policies and requirements.
Requirements
- At least 8 years of relevant work experience which could include sales, marketing, medical devices, or healthcare field.
- Specialty therapeutics/Rare Disease experience is a strongly preferred.
- Demonstrated strategic account management experience with health systems, IDNs, academic medical centers, hospitals, or large specialty-provider organizations.
- Strong understanding of health-system operations, organized customer decision-making, care-delivery models, value chain, formulary processes, coverage and reimbursement, and medical and pharmacy benefit dynamics.
- Demonstrated experience developing and executing comprehensive account strategies, needs assessments, stakeholder plans, and cross-functional action plans.
- Ability to synthesize qualitative and quantitative information from multiple sources, challenge assumptions, identify strategic opportunities, and translate insights into clear recommendations and account plans.
- Demonstrated ability to build trusted relationships and communicate credibly with senior executives, clinical leaders, key opinion leaders, and other complex customer stakeholders.
- Proven ability to mobilize cross-functional partners, lead without direct authority, manage competing priorities, and deliver results in a highly matrixed environment.
- Strong executive presence, written and verbal communication, presentation, and interpersonal skills.
- Working knowledge of healthcare data and business analytics tools, with the ability to apply insights to account strategy and decision-making.
- Ability to travel in accordance with the requirements of a field-based role, including convenient access to a major airport.
- Bachelor’s Degree or Equivalent, Scientific Degree and/or MBA strongly preferred.
Benefits
- 401(k) Matching
- Medical, Dental & Vision
- Life Insurance
- Short & Long-Term Disability
- Flexible Spending Accounts
- Parental Leave
- Paid Time Off
- Winter Shutdown
- Well-being Allowance
- Commuter Benefits
Company overview
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a global presence in over 40 countries. Founded in 1929 by Henri Beaufour, the company has evolved into a leading mid-size pharmaceutical firm specializing in three key therapeutic areas: oncology, rare diseases, and neuroscience. With approximately 5,300 employees worldwide, Ipsen operates as a publicly traded company on Euronext Paris while maintaining significant family ownership through the Beaufour family. The company's portfolio includes innovative treatments such as Cabometyx for advanced cancers, Dysport for neurological conditions, and Bylvay for rare liver diseases. Ipsen has established itself as one of the world's top 15 biopharmaceutical companies in oncology sales, with medicines registered in 88 countries and direct commercial operations in over 30 nations. The company maintains four global R&D hubs and three pharmaceutical development centers, investing significantly in research and development to advance transformative medicines for patients with limited treatment options.